ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,989,000 | – | 31,600 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 505,670 | $34,487,000 | 7.23% |
| Asymmetry Capital Management, L.P. | 142,246 | $9,701,000 | 6.67% |
| Prosight Management, LP | 137,000 | $9,343,000 | 5.84% |
| Avoro Capital Advisors LLC | 4,075,000 | $277,915,000 | 4.84% |
| Integral Health Asset Management, LLC | 225,000 | $15,345,000 | 4.22% |
| First Light Asset Management, LLC | 617,124 | $42,088,000 | 2.52% |
| SECTORAL ASSET MANAGEMENT INC | 322,599 | $22,001,000 | 1.78% |
| Avidity Partners Management LP | 943,000 | $64,313,000 | 1.74% |
| DAFNA Capital Management LLC | 119,615 | $8,158,000 | 1.71% |
| Nicholas Investment Partners, LP | 298,247 | $20,340,000 | 1.28% |